Skip to content

Nuvation Bio NUVB Change in AR

Change in AR at other companies

Pfizer logo
PfizerPFE
$65.75M+141%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$120K-101%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$0+100%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$700K-95.2%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$19.69M+303%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$6.5M+110%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's change in AR?
Nuvation Bio (NUVB) reported change in AR of $6.65M in Q1 2026.
How has Nuvation Bio's change in AR changed year-over-year?
Nuvation Bio's change in AR increased by 154.0% year-over-year, from -$12.31M to $6.65M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.